T Cell Responses in HIV Type 1-Infected Adolescent Minorities Share Similar Epitope Specificities with Whites Despite Significant Differences in HLA Class I Alleles

AIDS Research and Human Retroviruses

Volumn 19, Issue 11, 2003, Pages 1017-1026

  Bansal, Anju ^a   Korber, Bette ^c   Wilson, Craig M ^e   Kaslow, Richard A ^a,b   Mulligan, Mark J ^a,d   Sabbaj, Steffanie ^a   Edwards, Bradley H ^a   Ritter, Doug ^a   Perkins, Christopher ^a   Tang, James ^a,b   Szinger, James J ^c   Weiss, Heidi ^a   Goepfert, Paul A ^a,d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

^d University of Alabama at Birmingham   (United States)

^e University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAG PROTEIN; HLA ANTIGEN CLASS 1; NEF PROTEIN; PEPTIDE; POL PROTEIN; RNA DIRECTED DNA POLYMERASE; VIRUS ENVELOPE PROTEIN;

ADOLESCENT; ALLELE; CELLULAR IMMUNITY; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN DOMAIN; RACE DIFFERENCE; REVIEW; T LYMPHOCYTE; UNITED STATES; VIRUS CAPSID;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; AMINO ACID SEQUENCE; ANTI-HIV AGENTS; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; RETROVIRIDAE PROTEINS; T-LYMPHOCYTES;

EID: 10744230046     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203322588378     Document Type: Review

References (24)

1. Carrington M, Nelson GW, Martin MP, et al.: HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999;283:1748-1752.
2. Hendel H, Caillat-Zucman S, Lebuanec H, et al.: New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol 1999;162:6942-6946.
3. Kaslow RA, Carrington M, Apple R, et al.: Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996;2:405-411.
4. Keet IP, Tang J, Klein MR, et al.: Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis 1999;180:299-309.
5. Nelson GW, Kaslow R, and Mann DL: Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection. Proc Natl Acad USA 1997;94:9802-9807.
6. Tang J, Wilson CM, Meleth S, et al.: Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents. AIDS 2002;16:2275-2284.
7. Kaslow RA, Rivers C, Tang J, et al.: Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines. J Virol 2001;75:8681-8689.
8. Ogg GS, Jin X, Bonhoeffer S, et al.: Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998;279:2103-2106.
9. Jin X, Bauer DE, Tuttleton SE, et al.: Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999;189:991-998.
10. Edwards BH, Bansal A, Sabbaj S, et al.: Magnitude of functional CD8(+) T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J Virol 2002;76:2298-2305.
11. Korber BTM, Brander C, Haynes B, Koup R, Kuiken C, Moore J, Walker B, and Watkins D: HIV Molecular Immunology 2000. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, 2000.
12. Rogers AS, Futterman DK, Moscicki AB, et al.: The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: Design, methods, and selected characteristics of participants. J Adolesc Health 1998;22:300-311.
13. Wilson CM, Houser J, Partlow C, et al.: The REACH (Reaching for Excellence in Adolescent Care and Health) project: Study design, methods, and population profile. J Adolesc Health 2001;29: 8-18.
14. Douglas SD, Rudy B, Muenz L, et al.: Peripheral blood mononuclear cell markers in antiretroviral therapy - naive HIV-infected and high risk seronegative adolescents. Adolescent Medicine HIV/AIDS Research Network. AIDS 1999;13:1629-1635.
15. Holland CA, Ellenberg JH, Wilson CM, et al.: Relationship of CD4+ T cell counts and HIV type 1 viral loads in untreated, infected adolescents. Adolescent Medicine HIV/AIDS Research Network. AIDS Res Hum Retroviruses 2000;16:959-963.
16. Cao K, Hollenbach J, Shi X, et al.: Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol 2001;62:1009-1030.
17. Kuiken CL, Foley B, Hahn B, Korber B, McCutchan F, Marx PA, Mellors JW, Mullins JI, Sodroski J, and Wolinsky S (eds.): Human Retroviruses and AIDS 2001: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, 2001.
18. Addo MM, Altfeld M, Rosenberg ES, et al.: The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals. Proc Natl Acad Sci USA 2001;98:1781-1786.
19. Altfeld M, Addo MM, Eldridge RL, et al.: Vpr is preferentially targeted by CTL during HIV-1 infection. J Immunol 2001;167: 2743-2752.
20. Goulder PJ, Brander C, Annamalai K, et al.: Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. J Virol 2000;74:5679-5690.
21. Addo MM, Yu XG, Rathod A, et al.: Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genomic demonstrate broadly directed responses, but no correlation to viral load. J Virol 2003;77:2081-2092.
22. Kuiken CL, Foley B, Guzman E, and Korber BT: The determinants of HIV-1 protein evolution. In: The Evolution of HIV (Crandall KA, ed.). The John Hopkins University Press. Baltimore, MD, 1999, pp. 432-468.
23. Huang Y, Zhang L, and Ho DD: Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection. J Virol 1995;69:93-100.
24. Yusim K, Kesmir C, Gaschen B, et al.: Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J Virol 2002;76:8757-8768.